Apple CEO Steve Jobs does not have recurrent cancer or a life-threatening illness, a newspaper reports. Jobs' health has been a concern among Apple investors.
LOS ANGELES (Reuters) - Apple CEO Steve Jobs, who has been dogged by
investor concerns about his health, does not have recurrent cancer or a
life-threatening health issue, The New York Times reported on Saturday.
"While his health problems amounted to a good deal more than 'a
common bug,' they weren't life-threatening and he doesn't have a
recurrence of cancer," journalist Joe Nocera wrote in a column.
Nocera said he spoke to the Apple CEO about his health.
"Because the conversation was off the record, I cannot disclose what Mr. Jobs told me," Nocera said.
An Apple spokesman was not immediately available for comment.
In 2004, Jobs, 53, announced he had undergone successful surgery to remove a rare type of pancreatic cancer.
Concerns about his health roared back last month, when a
thinner-than-usual Jobs introduced the latest iteration of the iPhone
at a conference in San Francisco.
Apple, which first attributed the weight loss to a common bug, has
said repeatedly Jobs' health is a private matter. The lack of
disclosure from the company--well-known for its secrecy--caused
investors and analysts to fret.
On Wednesday, the Times reported Jobs had told associates he was doing well and was cancer free.
Citing people close to Jobs, the article said Jobs had told
associates and Apple directors he was dealing with nutritional problems
in the wake of his cancer surgery and that he had had surgery this year
to fix a problem contributing to his weight loss.
(Reporting by Lisa Baertlein; editing by Todd Eastham)
Copyright Reuters 2008. All rights reserved. Users
may download and print extracts of content from this website for their own
personal and non-commercial use only. Republication or redistribution of
Reuters content, including by framing or similar means, is expressly prohibited
without the prior written consent of Reuters. Reuters and the Reuters sphere
logo are registered trademarks or trademarks of the Reuters group of companies
around the world.